These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22107831)

  • 1. [Comments on the ESC/EAS guidelines for the management of dyslipidaemias 2011. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology].
    Anguita M; Alegría E; Barrios V; Casasnovas JA; Escobar C; León M; Luengo E; Llisterri JL; Alonso Á; Cequier Á; Comín J; Fernández-Ortiz A; Heras M; Pan M; Worner F
    Rev Esp Cardiol; 2011 Dec; 64(12):1090-5. PubMed ID: 22107831
    [No Abstract]   [Full Text] [Related]  

  • 2. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).
    ; Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WM; Vlachopoulos C; Wood DA; Zamorano JL
    Atherosclerosis; 2016 Oct; 253():281-344. PubMed ID: 27594540
    [No Abstract]   [Full Text] [Related]  

  • 3. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
    ; Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Perrone Filardi P; Riccardi G; Storey RF; Wood D;
    Atherosclerosis; 2011 Jul; 217 Suppl 1():S1-44. PubMed ID: 21723445
    [No Abstract]   [Full Text] [Related]  

  • 4. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
    Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman M; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D; ;
    Atherosclerosis; 2011 Jul; 217(1):3-46. PubMed ID: 21882396
    [No Abstract]   [Full Text] [Related]  

  • 5. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
    ; Reiner Z; Catapano AL; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D;
    Eur Heart J; 2011 Jul; 32(14):1769-818. PubMed ID: 21712404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Update Dyslipidaemias - Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias].
    Sinning D; Landmesser U
    Dtsch Med Wochenschr; 2017 Jun; 142(11):816-820. PubMed ID: 28564733
    [No Abstract]   [Full Text] [Related]  

  • 7. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
    Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WMM; Vlachopoulos C; Wood DA; Zamorano JL; Cooney MT;
    Eur Heart J; 2016 Oct; 37(39):2999-3058. PubMed ID: 27567407
    [No Abstract]   [Full Text] [Related]  

  • 8. [A perspective to lipid lowering therapy after ESC/EAS guidelines for the management of dyslipidaemias and the European guidelines on cardiovascular disease prevention in clinical practice].
    Ural D
    Turk Kardiyol Dern Ars; 2012 Jun; 40(4):293-7. PubMed ID: 22951844
    [No Abstract]   [Full Text] [Related]  

  • 9. [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: What is new?].
    Kayıkçıoğlu M; Tokgözoğlu L
    Turk Kardiyol Dern Ars; 2017 Mar; 45(2):109-112. PubMed ID: 28424431
    [No Abstract]   [Full Text] [Related]  

  • 10. [ECS guidelines 2016 - dyslipidaemias].
    Sinning D; Landmesser U
    Herz; 2016 Dec; 41(8):671-676. PubMed ID: 27844136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidelines related to the diagnostics and treatment of dyslipidemias issued in 2011].
    Soška V; Vaverková H; Vráblík M; Bláha V; Cífková R; Freiberger T; Kraml P; Piťha J; Rosolová H; Stulc T; Urbanová Z
    Vnitr Lek; 2013 Feb; 59(2):120-6. PubMed ID: 23461401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new joint EAS/ESC guidelines for the management of dyslipidaemias.
    Catapano AL; Chapman J; Wiklund O; Taskinen MR
    Atherosclerosis; 2011 Jul; 217(1):1. PubMed ID: 21722901
    [No Abstract]   [Full Text] [Related]  

  • 13. New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?
    Reiner Z
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):724-7. PubMed ID: 21945917
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments on the ESC guidelines on the management of valvular heart disease (version 2012). A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.
    ; ; ; Alonso Gómez ÁM; Gómez de Diego JJ; Barba J; Barón G; Borrás X; Evangelista A; Fernández González ÁL; García Orta R; Gómez Doblas JJ; Hernández Antolín R; Hernández García JM; Mahía P; Sáez de Ibarra JI; Bermejo J; Cuenca Castillo J; García Fernández MÁ; García Fuster R; López J; López Haldón JE; Tornos P; San Román A; Sitges M; Vilacosta I; Zamorano JL; Anguita M; Cequier Á; Comín J; Diaz-Buschmann I; Fernández Lozano I; Fernández-Ortiz A; Pan M; Wornerm F
    Rev Esp Cardiol (Engl Ed); 2013 Feb; 66(2):85-9. PubMed ID: 24775380
    [No Abstract]   [Full Text] [Related]  

  • 15. 'Ten Commandments' from the 2016 ESC/EAS Guidelines for the management of dyslipidaemias.
    Eur Heart J; 2016 Oct; 37(39):2966. PubMed ID: 27923853
    [No Abstract]   [Full Text] [Related]  

  • 16. [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias].
    Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WM; Vlachopoulos C; Wood DA; Zamorano JL
    Kardiol Pol; 2016; 74(11):1234-1318. PubMed ID: 27910077
    [No Abstract]   [Full Text] [Related]  

  • 17. Comments on the ESC/ESH guidelines for the management of arterial hypertension 2013. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.
    Grupo de Trabajo de la SEC sobre la guía de hipertensión arterial ESC/ESH 2013, revisores expertos de la guía de hipertensión arterial ESC/ESH 2013 y Comité de Guías de Práctica Clínica de la SEC
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):842-7. PubMed ID: 24773990
    [No Abstract]   [Full Text] [Related]  

  • 18. Comments on the ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.
    Anguita M; Comin J; Almenar L; Crespo M; Delgado J; Gonzalez-Costello J; Hernandez-Madrid A; Manito N; Perez de la Sota E; Segovia J; Segura C; Alonso-Gomez AM; Anguita M; Cequier A; Comin J; Diaz-Buschmann I; Fernandez-Lozano I; Fernandez-Ortiz A; Gomez de Diego JJ; Pan M; Worner F; Alonso-Pulpon L; Bover R; Castro A; Diaz-Molina B; Gomez-Bueno M; Gonzalez-Juanatey JR; Lage E; Lopez-Granados A; Lupon J; Martinez-Dolz L; Munoz R; Pascual D; Ridocci F; Roig E; Varela A; Vazquez de Prada JA
    Rev Esp Cardiol (Engl Ed); 2012 Oct; 65(10):874-8. PubMed ID: 22999110
    [No Abstract]   [Full Text] [Related]  

  • 19. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
    Mach F; Baigent C; Catapano AL; Koskinas KC; Casula M; Badimon L; Chapman MJ; De Backer GG; Delgado V; Ference BA; Graham IM; Halliday A; Landmesser U; Mihaylova B; Pedersen TR; Riccardi G; Richter DJ; Sabatine MS; Taskinen MR; Tokgozoglu L; Wiklund O;
    Eur Heart J; 2020 Jan; 41(1):111-188. PubMed ID: 31504418
    [No Abstract]   [Full Text] [Related]  

  • 20. Comments on the ESC guidelines on cardiovascular disease prevention (version 2012). A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.
    Diaz-Buschmann I; Castro A; Galve E; Calero MJ; Dalmau R; Guzmán G; Cordero A; Fácila L; Quiles J; Arrarte V; Diaz-Buschmann I; Alonso Gómez ÁM; Cequier Á; Comín J; Fernández-Ortiz A; Pan M; Fernández Lozano FW; Fernández-Ortiz A; Sanmartín M; Ferreira I; Brotons C; López Sendón JL; Mazón P; Alonso J; Abeytua M; González Juanatey JR; de Pablo C; Worner F; Castro-Beiras A;
    Rev Esp Cardiol (Engl Ed); 2012 Oct; 65(10):869-73. PubMed ID: 22999109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.